Antiatherosclerosis interventions in women

Area of Science:

• Cardiovascular Health
• Women's Health
• Endocrinology

Background:

• Atherosclerosis progression and cardiovascular events in women require multifaceted prevention strategies beyond solely lowering low-density lipoprotein cholesterol.
• Hormone replacement therapy (HRT) presents a complex option due to conflicting clinical trial outcomes.
• Menopause-associated hormonal changes impact cardiovascular risk, necessitating further investigation into therapeutic interventions.

Purpose of the Study:

• To explore the role of hormone replacement therapy (HRT) in mitigating atherosclerosis progression and cardiovascular events in women.
• To identify optimal strategies for HRT, considering timing, type, dose, and regimen.
• To highlight the potential of advanced imaging in evaluating HRT's impact on cardiovascular health.

Main Methods:

• Review of surrogate endpoint studies and secondary prevention randomized clinical trials on HRT.
• Analysis of the atherosclerotic process during the early menopausal transition.
• Utilization of advanced imaging techniques for monitoring atherosclerosis progression.

Main Results:

• Lowering low-density lipoprotein cholesterol alone is not sufficient for optimal cardiovascular event prevention in women.
• Early intervention with HRT during the quiescent phase of atherosclerosis in early menopause may be key.
• Conflicting results from studies complicate the use of HRT for cardiovascular risk reduction.

Conclusions:

• HRT for reducing cardiovascular events in women is not a simple intervention.
• The timing of HRT initiation, particularly during early menopause, is crucial.
• Advanced imaging tools are essential for answering remaining questions about HRT's efficacy and safety in women's cardiovascular health.